Bristol-Myers Squibb Co.

UPDATE: Bristol, AstraZeneca Diabetes Drug Fails to Cut Heart Risk

Amgen In Focus

Sector Update: Healthcare Shares Slightly Higher in Pre-Market; Vanda Pharmaceuticals Down 11% on Su

Sector Update: Healthcare

AstraZeneca: Preliminary Savor-Timi-53 Data Being Analyzed

AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outc

Medtronic Saga: Corrupt Science, Belated Warning

Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore Thei

Team Alpha Retirement Portfolio: Use The Cycle Rotation To Grow Dividends And Gains

Where Is Biotechnology's Next 'Anti-PD-1'?